infectious disease

Virtual trials, COVID-19, & the future
Virtual trials, COVID-19, and the future of the industry As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option...
April 21, 2020
No Comments
Industry News: COVID-19

Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and treatment of the virus. Explore PharPoint’s news roundup and learn more about our extensive infectious disease experience.

February 4, 2020
No Comments